IL13 and Increased total eosinophil count: Intriguingly, although Frisbee et al. concluded that IL-33-induced protection was related to the action of type 2 innate lymphoid cells (ILC2s), through enhanced levels of IL-5, IL-13, and eosinophilia (34), we observed no enhanced expression of these cytokines following drug treatment.